Clinically, if our findings regarding genetic vulnerability in DNA repair are replicated in larger and independent cohorts, they may eventually inform the development of more specific diagnostic tools and targeted interventions for infection-associated psychiatric episodes and behavioral decompensation, potentially by modulating overactive immune pathways such as type I interferons and AIM2 inflammasomes. This evidence concerns the gene AIM2 and infection.